TTRX
Turn Therapeutics Inc.
Latest Form 4:Purchase$9KbyChaudhary Zuraiz (See Remarks) · filed Dec 12, 2025
Turn Therapeutics Inc. (TTRX) has 11 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 1, 2026.
The most active filer is See Remarks Chaudhary Zuraiz with 5 filings.
- Industry:Biotechnology
- CEO:Bradley E. Burnam
- Employees:2
- HQ:Westlake Village, CA, US
- IPO:2025-10-08
Insider Buying
$275K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$284.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| See Remarks | Purchase | 2,500 | $9K | Dec 12 | SEC ↗ | |
| Director | Purchase | 20,532 | $59K | Nov 24 | SEC ↗ | |
| See Remarks | Purchase | 1,450 | $4K | Nov 21 | SEC ↗ | |
| See Remarks | Purchase | 1,000 | $3K | Nov 21 | SEC ↗ | |
| See Remarks | Purchase | 2,500 | $9K | Nov 17 | SEC ↗ | |
Chesed AbrahamFirst filing | Board Observer | Purchase | 14,286 | $66K | Oct 29 | SEC ↗ |
Chaudhary ZuraizFirst filing | See Remarks | Purchase | 5,050 | $25K | Oct 23 | SEC ↗ |
GOLDEN ARTHUR FFirst filing | Director | Purchase | 20,202 | $100K | Oct 23 | SEC ↗ |
Related companies
Turn Therapeutics Inc. is in the Healthcare sector.